HIV Archives

News and Trends 16 Nov 2017

German Scientists Test Out New HIV Vaccine Combinations in Animals

Scientists from the German Primate Center have investigated the impact of the delivery route and order of components on the success of an HIV vaccine. With more than 36 million people infected with the human immunodeficiency virus (HIV) and a further 2.4 million infected each year, something needs to be done. Researchers from the German […]

November 16, 2017 - 3 minutesmins - By Alex Dale

Interview 23 Oct 2017

The German CEO Pushing for an Immunotherapy to Treat Cancer and HIV

Mariola Söhngen, CEO of Mologen, discusses biotech entrepreneurship in Germany and her company’s unique immunotherapy against both cancer and HIV. Mariola Söhngen has an outstanding track record as an entrepreneur and leader in biotech and pharma. In 1998, after 10 years working with big pharma, she founded her first company, Bootcamp, to help young professionals […]

October 23, 2017 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Oct 2017

Market Ready HIV Self-Test Gets the Thumbs Up from the European Union

Technology allowing individuals to accurately test themselves for HIV has received a CE Mark from the EU, meaning it can soon be released onto the market. The EU has awarded a CE Mark to an HIV self-test, developed by world-leading diagnostics developer, Atomo Diagnostics, Sydney, Australia. The world’s first at-home device detects the presence of Human Immunodeficiency Virus […]

October 10, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Sep 2017

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Abivax’s HIV cure candidate, ABX464, caused a significant drop in the viral reservoir over an extended period during a Phase IIa study. Abivax targets the immune system to cure viral diseases. The company has announced initial results from the first cohort of patients in its most recent Phase IIa trial testing its potential HIV cure, ABX464. Initial […]

September 28, 2017 - 2 minutesmins - By Alex Dale

News and Trends 27 Sep 2017

Belgian Pharma’s Single-Tablet HIV Treatment Approved in the EU

Janssen’s single-tablet regimen, Symtuza, has been approved by the European Commission for the treatment of HIV in adults and adolescents in the EU. The pharmaceutical arm of Johnson & Johnson, Janssen, has announced that the European Commission has approved its single-tablet regimen (STR), Symtuza, to treat Human Immunodeficiency Virus (HIV) infections. Previous studies have demonstrated […]

September 27, 2017 - 3 minutesmins - By Alex Dale

News and Trends 25 Sep 2017

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

Sanofi, in collaboration with the US National Institute of Health, is developing an antibody HIV treatment that can kill 99% of strains. Human immunodeficiency virus (HIV) is notoriously difficult to treat as it mutates so quickly. Some patients develop ‘broadly neutralizing antibodies’ that attack fundamental parts of the virus, and are therefore very powerful tools. Researchers […]

September 25, 2017 - 3 minutesmins - By Alex Dale

News and Trends 18 Sep 2017

British Unicorn Gets $40M Boost from Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation have injected $40M (€33M) into Immunocore to accelerate the development of its immunotherapies for infectious diseases. Investment from the Bill & Melinda Gates Foundation will support the development of Immunocore’s ImmTAV and ImmTAB TCR-based technologies, which help the immune system to target virally and bacterially infected cells, respectively. In particular, […]

September 18, 2017 - 2 minutesmins - By Alex Dale

Infographics 13 Sep 2017

The 10 Most Innovative HIV Treatments to Defeat AIDS

This infographic gathers 10 of the best HIV treatments in Europe’s pipeline that will help doctors worldwide fight against AIDS better than ever before. With an estimated 36.7 million people living with HIV worldwide, the search for an effective treatment that can overcome the fast evolution of the virus is rapidly gaining traction. In Europe, […]

September 13, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 1 Aug 2017

Potential Herpes Cure from Germany Fast-Tracked for Patients with Weak Immune Systems

AiCuris’ Pritelivir has now secured FDA endorsement in the form of a Fast Track Designation in immuno-compromised patients. Based in Wuppertal, Germany, and spun out from Bayer, AiCuris is focused on curing infectious diseases. Its lead candidate for herpes simplex viruses 1 and 2 (HSV-1 and -2), pritelivir, has been watched closely for its promise […]

August 1, 2017 - 2 minutesmins - By Editorial Team

News and Trends 11 May 2017

HIV Treatment Development Extends Life Expectancy by 10 Years

According to a new study, the life expectancy of 20-year-olds starting HIV treatment has increased by a decade in the EU and North America. A massive new study from the UK was published today in The Lancet HIV. The study tracked how many HIV patients died during the first three years of HIV treatment, their cause […]

May 11, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 2 May 2017

French HIV Cure Reduces Viral Reservoirs for the First Time Ever

Abivax has announced results from a Phase IIa trial that reveal the first proof in human of viral load reduction of hidden HIV reservoirs. Abivax is developing a functional HIV cure that, unlike current antiretroviral therapy (ART), could completely eliminate the virus and prevent it from coming back when the treatment is stopped. Results from a Phase IIa […]

May 2, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 15 Mar 2017

France Closes in on an HIV Cure by Detecting Cells with Dormant Viruses

French researchers have found a protein only expressed in HIV-infected reservoir cells, paving the way for an HIV cure that completely eliminates the virus. Researchers from the Institut de Génétique Humaine (IGH) at Montpellier University, France, have discovered a protein, CD32a, that is only present on the surface of CD4 T cells infected with dormant HIV. This […]

March 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

HIV

German Scientists Test Out New HIV Vaccine Combinations in Animals

The German CEO Pushing for an Immunotherapy to Treat Cancer and HIV

Market Ready HIV Self-Test Gets the Thumbs Up from the European Union

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Belgian Pharma’s Single-Tablet HIV Treatment Approved in the EU

Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains

British Unicorn Gets $40M Boost from Bill & Melinda Gates Foundation

The 10 Most Innovative HIV Treatments to Defeat AIDS

Potential Herpes Cure from Germany Fast-Tracked for Patients with Weak Immune Systems

HIV Treatment Development Extends Life Expectancy by 10 Years

French HIV Cure Reduces Viral Reservoirs for the First Time Ever

France Closes in on an HIV Cure by Detecting Cells with Dormant Viruses

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!